Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center
Introduction The preservation of fertility is an integral part of care of children requiring gonadotoxic treatments for cancer or non‐malignant diseases. In France, the cryopreservation of ovarian tissue has been considered and has been offered as a clinical treatment since its inception. The aim of...
Uloženo v:
| Vydáno v: | Acta obstetricia et gynecologica Scandinavica Ročník 98; číslo 5; s. 630 - 637 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
John Wiley & Sons, Inc
01.05.2019
|
| Témata: | |
| ISSN: | 0001-6349, 1600-0412, 1600-0412 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Introduction
The preservation of fertility is an integral part of care of children requiring gonadotoxic treatments for cancer or non‐malignant diseases. In France, the cryopreservation of ovarian tissue has been considered and has been offered as a clinical treatment since its inception. The aim of this study is to review 20 years of activity in fertility preservation by ovarian tissue cryopreservation (OTC) for children and the feasibility of oocyte isolation and cryopreservation from the ovarian tissue at a single center.
Material and methods
Retrospective study including patients aged 15 years or younger who underwent OTC, combined for some with oocyte cryopreservation of isolated oocytes, before a highly gonadotoxic treatment for malignant or non‐malignant disease was initiated. We describe the evolution of activities in our program for fertility preservation and patient characteristics at the time of OTC and follow up.
Results
From April 1998 to December 2018, 418 girls and adolescents younger than 15 years of age underwent OTC, representing 40.5% of all females who have had ovarian tissue cryopreserved at our center. In all, 313 patients had malignant diseases and 105 had benign conditions. Between November 2009 and July 2013, oocytes were isolated and also cryopreserved in 50 cases. The mean age of patients was 6.9 years (range 0.3‐15). The most frequent diagnoses in this cohort included neuroblastoma, acute leukemia and hemoglobinopathies; neuroblastoma being the most common diagnosis in very young patients. During follow up, three patients requested the use of their cryopreserved ovarian tissue. All had undergone ovarian tissue transplantation, one for puberty induction and the two others for restoring fertility. So far, no pregnancies have been achieved. Eighty‐four patients who had OTC died.
Conclusions
Ovarian tissue cryopreservation is the only available technique for preserving fertility of girls. To our knowledge this is the largest series of girls and adolescents younger than 15 years so far reported on procedures of OTC before highly gonadotoxic treatment in a single center. |
|---|---|
| AbstractList | The preservation of fertility is an integral part of care of children requiring gonadotoxic treatments for cancer or non-malignant diseases. In France, the cryopreservation of ovarian tissue has been considered and has been offered as a clinical treatment since its inception. The aim of this study is to review 20 years of activity in fertility preservation by ovarian tissue cryopreservation (OTC) for children and the feasibility of oocyte isolation and cryopreservation from the ovarian tissue at a single center.INTRODUCTIONThe preservation of fertility is an integral part of care of children requiring gonadotoxic treatments for cancer or non-malignant diseases. In France, the cryopreservation of ovarian tissue has been considered and has been offered as a clinical treatment since its inception. The aim of this study is to review 20 years of activity in fertility preservation by ovarian tissue cryopreservation (OTC) for children and the feasibility of oocyte isolation and cryopreservation from the ovarian tissue at a single center.Retrospective study including patients aged 15 years or younger who underwent OTC, combined for some with oocyte cryopreservation of isolated oocytes, before a highly gonadotoxic treatment for malignant or non-malignant disease was initiated. We describe the evolution of activities in our program for fertility preservation and patient characteristics at the time of OTC and follow up.MATERIAL AND METHODSRetrospective study including patients aged 15 years or younger who underwent OTC, combined for some with oocyte cryopreservation of isolated oocytes, before a highly gonadotoxic treatment for malignant or non-malignant disease was initiated. We describe the evolution of activities in our program for fertility preservation and patient characteristics at the time of OTC and follow up.From April 1998 to December 2018, 418 girls and adolescents younger than 15 years of age underwent OTC, representing 40.5% of all females who have had ovarian tissue cryopreserved at our center. In all, 313 patients had malignant diseases and 105 had benign conditions. Between November 2009 and July 2013, oocytes were isolated and also cryopreserved in 50 cases. The mean age of patients was 6.9 years (range 0.3-15). The most frequent diagnoses in this cohort included neuroblastoma, acute leukemia and hemoglobinopathies; neuroblastoma being the most common diagnosis in very young patients. During follow up, three patients requested the use of their cryopreserved ovarian tissue. All had undergone ovarian tissue transplantation, one for puberty induction and the two others for restoring fertility. So far, no pregnancies have been achieved. Eighty-four patients who had OTC died.RESULTSFrom April 1998 to December 2018, 418 girls and adolescents younger than 15 years of age underwent OTC, representing 40.5% of all females who have had ovarian tissue cryopreserved at our center. In all, 313 patients had malignant diseases and 105 had benign conditions. Between November 2009 and July 2013, oocytes were isolated and also cryopreserved in 50 cases. The mean age of patients was 6.9 years (range 0.3-15). The most frequent diagnoses in this cohort included neuroblastoma, acute leukemia and hemoglobinopathies; neuroblastoma being the most common diagnosis in very young patients. During follow up, three patients requested the use of their cryopreserved ovarian tissue. All had undergone ovarian tissue transplantation, one for puberty induction and the two others for restoring fertility. So far, no pregnancies have been achieved. Eighty-four patients who had OTC died.Ovarian tissue cryopreservation is the only available technique for preserving fertility of girls. To our knowledge this is the largest series of girls and adolescents younger than 15 years so far reported on procedures of OTC before highly gonadotoxic treatment in a single center.CONCLUSIONSOvarian tissue cryopreservation is the only available technique for preserving fertility of girls. To our knowledge this is the largest series of girls and adolescents younger than 15 years so far reported on procedures of OTC before highly gonadotoxic treatment in a single center. The preservation of fertility is an integral part of care of children requiring gonadotoxic treatments for cancer or non-malignant diseases. In France, the cryopreservation of ovarian tissue has been considered and has been offered as a clinical treatment since its inception. The aim of this study is to review 20 years of activity in fertility preservation by ovarian tissue cryopreservation (OTC) for children and the feasibility of oocyte isolation and cryopreservation from the ovarian tissue at a single center. Retrospective study including patients aged 15 years or younger who underwent OTC, combined for some with oocyte cryopreservation of isolated oocytes, before a highly gonadotoxic treatment for malignant or non-malignant disease was initiated. We describe the evolution of activities in our program for fertility preservation and patient characteristics at the time of OTC and follow up. From April 1998 to December 2018, 418 girls and adolescents younger than 15 years of age underwent OTC, representing 40.5% of all females who have had ovarian tissue cryopreserved at our center. In all, 313 patients had malignant diseases and 105 had benign conditions. Between November 2009 and July 2013, oocytes were isolated and also cryopreserved in 50 cases. The mean age of patients was 6.9 years (range 0.3-15). The most frequent diagnoses in this cohort included neuroblastoma, acute leukemia and hemoglobinopathies; neuroblastoma being the most common diagnosis in very young patients. During follow up, three patients requested the use of their cryopreserved ovarian tissue. All had undergone ovarian tissue transplantation, one for puberty induction and the two others for restoring fertility. So far, no pregnancies have been achieved. Eighty-four patients who had OTC died. Ovarian tissue cryopreservation is the only available technique for preserving fertility of girls. To our knowledge this is the largest series of girls and adolescents younger than 15 years so far reported on procedures of OTC before highly gonadotoxic treatment in a single center. IntroductionThe preservation of fertility is an integral part of care of children requiring gonadotoxic treatments for cancer or non‐malignant diseases. In France, the cryopreservation of ovarian tissue has been considered and has been offered as a clinical treatment since its inception. The aim of this study is to review 20 years of activity in fertility preservation by ovarian tissue cryopreservation (OTC) for children and the feasibility of oocyte isolation and cryopreservation from the ovarian tissue at a single center.Material and methodsRetrospective study including patients aged 15 years or younger who underwent OTC, combined for some with oocyte cryopreservation of isolated oocytes, before a highly gonadotoxic treatment for malignant or non‐malignant disease was initiated. We describe the evolution of activities in our program for fertility preservation and patient characteristics at the time of OTC and follow up.ResultsFrom April 1998 to December 2018, 418 girls and adolescents younger than 15 years of age underwent OTC, representing 40.5% of all females who have had ovarian tissue cryopreserved at our center. In all, 313 patients had malignant diseases and 105 had benign conditions. Between November 2009 and July 2013, oocytes were isolated and also cryopreserved in 50 cases. The mean age of patients was 6.9 years (range 0.3‐15). The most frequent diagnoses in this cohort included neuroblastoma, acute leukemia and hemoglobinopathies; neuroblastoma being the most common diagnosis in very young patients. During follow up, three patients requested the use of their cryopreserved ovarian tissue. All had undergone ovarian tissue transplantation, one for puberty induction and the two others for restoring fertility. So far, no pregnancies have been achieved. Eighty‐four patients who had OTC died.ConclusionsOvarian tissue cryopreservation is the only available technique for preserving fertility of girls. To our knowledge this is the largest series of girls and adolescents younger than 15 years so far reported on procedures of OTC before highly gonadotoxic treatment in a single center. Introduction The preservation of fertility is an integral part of care of children requiring gonadotoxic treatments for cancer or non‐malignant diseases. In France, the cryopreservation of ovarian tissue has been considered and has been offered as a clinical treatment since its inception. The aim of this study is to review 20 years of activity in fertility preservation by ovarian tissue cryopreservation (OTC) for children and the feasibility of oocyte isolation and cryopreservation from the ovarian tissue at a single center. Material and methods Retrospective study including patients aged 15 years or younger who underwent OTC, combined for some with oocyte cryopreservation of isolated oocytes, before a highly gonadotoxic treatment for malignant or non‐malignant disease was initiated. We describe the evolution of activities in our program for fertility preservation and patient characteristics at the time of OTC and follow up. Results From April 1998 to December 2018, 418 girls and adolescents younger than 15 years of age underwent OTC, representing 40.5% of all females who have had ovarian tissue cryopreserved at our center. In all, 313 patients had malignant diseases and 105 had benign conditions. Between November 2009 and July 2013, oocytes were isolated and also cryopreserved in 50 cases. The mean age of patients was 6.9 years (range 0.3‐15). The most frequent diagnoses in this cohort included neuroblastoma, acute leukemia and hemoglobinopathies; neuroblastoma being the most common diagnosis in very young patients. During follow up, three patients requested the use of their cryopreserved ovarian tissue. All had undergone ovarian tissue transplantation, one for puberty induction and the two others for restoring fertility. So far, no pregnancies have been achieved. Eighty‐four patients who had OTC died. Conclusions Ovarian tissue cryopreservation is the only available technique for preserving fertility of girls. To our knowledge this is the largest series of girls and adolescents younger than 15 years so far reported on procedures of OTC before highly gonadotoxic treatment in a single center. |
| Author | Martelli, Helene Michon, Jean Lezeau, Harry Doz, Francois Yakouben, Karima Dufour, Christelle Neven, Benedicte Poirot, Catherine Prades‐Borio, Marie Valteau‐Couanet, Dominique Lambert, Guenolee Wolf, Jean‐Philippe Baruchel, Andre Minard, Veronique Pacquement, Helene Pondarre, Corinne Laurence, Valerie Sarnacki, Sabine Marzouk, Flora Brugieres, Laurence Bernaudin, Francoise Dalle, Jean‐Hugues Philippe‐Chomette, Pascale Drouineaud, Veronique Chalas, Celine Boissel, Nicolas Dhedin, Nathalie Paye‐Jaouen, Annabel |
| Author_xml | – sequence: 1 givenname: Catherine orcidid: 0000-0002-8043-7506 surname: Poirot fullname: Poirot, Catherine email: catherine.poirot@aphp.fr organization: Sorbonne University – sequence: 2 givenname: Laurence surname: Brugieres fullname: Brugieres, Laurence organization: Gustave Roussy Institute – sequence: 3 givenname: Karima surname: Yakouben fullname: Yakouben, Karima organization: Hospital Robert Debré – sequence: 4 givenname: Marie surname: Prades‐Borio fullname: Prades‐Borio, Marie organization: Hospital Tenon – sequence: 5 givenname: Flora surname: Marzouk fullname: Marzouk, Flora organization: Hospital Delafontaine – sequence: 6 givenname: Guenolee surname: Lambert fullname: Lambert, Guenolee organization: Hospital Bicêtre – sequence: 7 givenname: Helene surname: Pacquement fullname: Pacquement, Helene organization: Institut Curie – sequence: 8 givenname: Francoise surname: Bernaudin fullname: Bernaudin, Francoise organization: Center Hospitalier Intercommunal de Créteil – sequence: 9 givenname: Benedicte surname: Neven fullname: Neven, Benedicte organization: Paris‐Descartes University – sequence: 10 givenname: Annabel surname: Paye‐Jaouen fullname: Paye‐Jaouen, Annabel organization: Hospital Robert Debré – sequence: 11 givenname: Corinne surname: Pondarre fullname: Pondarre, Corinne organization: Center Hospitalier Intercommunal de Créteil – sequence: 12 givenname: Nathalie surname: Dhedin fullname: Dhedin, Nathalie organization: Hôpital Saint Louis – sequence: 13 givenname: Veronique surname: Drouineaud fullname: Drouineaud, Veronique organization: Hospital Cochin – sequence: 14 givenname: Celine surname: Chalas fullname: Chalas, Celine organization: Hospital Cochin – sequence: 15 givenname: Helene surname: Martelli fullname: Martelli, Helene organization: Paris‐Sud University – sequence: 16 givenname: Jean surname: Michon fullname: Michon, Jean organization: Institut Curie – sequence: 17 givenname: Veronique surname: Minard fullname: Minard, Veronique organization: Gustave Roussy Institute – sequence: 18 givenname: Harry surname: Lezeau fullname: Lezeau, Harry organization: Center Hospitalier Intercommunal de Créteil – sequence: 19 givenname: Francois surname: Doz fullname: Doz, Francois organization: Institut Curie – sequence: 20 givenname: Sabine surname: Sarnacki fullname: Sarnacki, Sabine organization: Hospital Necker – sequence: 21 givenname: Pascale surname: Philippe‐Chomette fullname: Philippe‐Chomette, Pascale organization: Hospital Robert Debré – sequence: 22 givenname: Christelle surname: Dufour fullname: Dufour, Christelle organization: Gustave Roussy Institute – sequence: 23 givenname: Valerie surname: Laurence fullname: Laurence, Valerie organization: Institut Curie – sequence: 24 givenname: Andre surname: Baruchel fullname: Baruchel, Andre organization: Paris‐Diderot University – sequence: 25 givenname: Jean‐Philippe surname: Wolf fullname: Wolf, Jean‐Philippe organization: Hospital Cochin – sequence: 26 givenname: Nicolas surname: Boissel fullname: Boissel, Nicolas organization: Paris‐Diderot University – sequence: 27 givenname: Dominique surname: Valteau‐Couanet fullname: Valteau‐Couanet, Dominique organization: Gustave Roussy Institute – sequence: 28 givenname: Jean‐Hugues surname: Dalle fullname: Dalle, Jean‐Hugues organization: Paris‐Diderot University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30919447$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kcFu1DAQhi1URLeFCw-ARuKCkLLYiZOsj1UFBanSHijnyHHGqSuvHWynbd6GV4Enw-2WSlQIX8aWv3809ndEDpx3SMhrRtcsrw_Sj3HNqoY1z8iKNZQWlLPygKwopaxoKi4OyVGMV_lUtnzzghxWVDDBebsiP7fXMhjpIJkYZwQVFj8FjBiuZTLegfYBNIZkrEkL_HVlHHC2gdEEG0G6AeTgLUaFLkWYJ0geWP3rx4IyRPAa5IigpTJuhEszXtoFRu9yJvlboyAFlGmXs2u4uMllgccg3k4YDDqFIBNIiLmFzbNmCsNL8lxLG_HVQz0m3z59vDj9XJxvz76cnpwXiteiKZq6lr3QLWMcB6YroaVuGiVE3eZNP8hB9Ewq5BulG91WWA-bHrWgvB5arPrqmLzb952C_z5jTN3O5LdaKx36OXYlE_lTWdlUGX37BL3yc3B5uq4sGStFFlNn6s0DNfc7HLopmJ0MS_dHTgbe7wEVfIwB9SPCaHdnvrsz392bzzB9AiuT7j2lII39d4TtIzfG4vKf5t3J9uzrPvMb127Fpw |
| CitedBy_id | crossref_primary_10_3390_jcm11051196 crossref_primary_10_3389_fendo_2019_00655 crossref_primary_10_3389_fendo_2023_1147898 crossref_primary_10_1182_bloodadvances_2023011536 crossref_primary_10_3390_ijms25084360 crossref_primary_10_1016_j_eururo_2024_03_025 crossref_primary_10_1093_humupd_dmac003 crossref_primary_10_1093_humrep_dead162 crossref_primary_10_1186_s12885_020_07227_z crossref_primary_10_1371_journal_pone_0323867 crossref_primary_10_1016_j_ejca_2022_05_013 crossref_primary_10_3389_fendo_2022_1074603 crossref_primary_10_1136_bcr_2020_241417 crossref_primary_10_1016_j_fertnstert_2021_05_096 crossref_primary_10_1016_S1470_2045_20_30594_5 crossref_primary_10_1007_s10815_025_03447_z crossref_primary_10_1016_j_ejogrb_2023_11_004 crossref_primary_10_1111_jog_15199 crossref_primary_10_3390_jcm8101523 crossref_primary_10_1111_aogs_13984 crossref_primary_10_1007_s10815_023_02958_x crossref_primary_10_1016_j_maturitas_2024_107922 crossref_primary_10_1177_14777509231216928 crossref_primary_10_1007_s10815_023_02932_7 crossref_primary_10_1186_s12958_025_01388_x crossref_primary_10_3389_fendo_2022_918899 crossref_primary_10_1016_j_jpedsurg_2024_02_015 crossref_primary_10_3390_jcm10225247 crossref_primary_10_2217_fon_2022_0078 crossref_primary_10_1007_s10815_020_01850_2 crossref_primary_10_1016_j_jogoh_2020_102029 crossref_primary_10_3389_fendo_2020_593718 crossref_primary_10_3390_jcm11092318 crossref_primary_10_1007_s10815_023_02948_z crossref_primary_10_1007_s40620_023_01670_4 crossref_primary_10_1007_s43032_021_00591_6 crossref_primary_10_1080_03009734_2020_1737601 crossref_primary_10_3389_fendo_2023_1158405 crossref_primary_10_1007_s10815_023_02945_2 crossref_primary_10_1007_s00383_021_04900_7 crossref_primary_10_3390_jcm10235690 crossref_primary_10_1016_j_jpag_2022_12_001 crossref_primary_10_1016_j_jpag_2024_11_002 crossref_primary_10_1016_j_fertnstert_2024_07_005 crossref_primary_10_1093_humrep_deaa353 crossref_primary_10_1089_jayao_2021_0209 crossref_primary_10_1016_j_ajog_2025_02_007 crossref_primary_10_3390_ijms20194720 crossref_primary_10_3390_life14030393 crossref_primary_10_3390_bioengineering11060543 crossref_primary_10_1007_s10147_025_02757_7 crossref_primary_10_1089_jayao_2023_0148 crossref_primary_10_1159_000516087 crossref_primary_10_1016_j_canep_2022_102189 crossref_primary_10_1530_REP_22_0114 crossref_primary_10_1111_aogs_14290 crossref_primary_10_3389_fsurg_2024_1352698 crossref_primary_10_3390_cancers15123141 crossref_primary_10_1016_j_rbmo_2020_01_009 crossref_primary_10_1002_pbc_31181 crossref_primary_10_3390_cancers13020202 crossref_primary_10_1016_j_rbmo_2021_10_009 crossref_primary_10_3389_fendo_2022_1035109 crossref_primary_10_3389_fendo_2024_1332673 |
| Cites_doi | 10.1155/2012/139193 10.2217/fon-2017-0410 10.1002/pbc.22003 10.1002/pbc.21027 10.1093/humupd/dmq010 10.1016/S0140-6736(11)61781-9 10.1182/blood.V87.7.3045.bloodjournal8773045 10.1016/j.fertnstert.2008.07.013 10.1093/humrep/dev128 10.1093/humrep/dew007 10.1016/j.ejca.2012.09.028 10.1111/aogs.13559 10.1056/NEJMra1614676 10.1093/humrep/17.6.1447 10.1155/2012/910698 10.1016/S0015-0282(02)04963-4 10.1016/j.jpedsurg.2006.12.041 10.1093/humrep/16.3.411 10.1016/S1470-2045(14)70334-1 10.1002/(SICI)1097-0142(19990815)86:4<697::AID-CNCR20>3.0.CO;2-J 10.1007/s10815-012-9909-5 10.1093/humrep/dex040 |
| ContentType | Journal Article |
| Copyright | 2019 Nordic Federation of Societies of Obstetrics and Gynecology 2019 Nordic Federation of Societies of Obstetrics and Gynecology. Copyright © 2019 Acta Obstetricia et Gynecologica Scandinavica |
| Copyright_xml | – notice: 2019 Nordic Federation of Societies of Obstetrics and Gynecology – notice: 2019 Nordic Federation of Societies of Obstetrics and Gynecology. – notice: Copyright © 2019 Acta Obstetricia et Gynecologica Scandinavica |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
| DOI | 10.1111/aogs.13616 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1600-0412 |
| EndPage | 637 |
| ExternalDocumentID | 30919447 10_1111_aogs_13616 AOGS13616 |
| Genre | article Journal Article |
| GeographicLocations | France |
| GeographicLocations_xml | – name: France |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 1OB 1OC 23M 24P 31~ 33P 34G 36B 39C 3O- 3SF 4.4 50Y 50Z 52M 52O 52T 52U 52V 52W 53G 5GY 5HH 5RE 5VS 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANHP AAONW AAPXX AAYCA AAZKR ABCUV ABJNI ABPVW ABTOO ABUWG ACAHQ ACBWZ ACCFJ ACCMX ACGFS ACMXC ACPOU ACRPL ACXQS ACYXJ ADBBV ADCVX ADEOM ADIYS ADIZJ ADKYN ADMGS ADNMO ADOZA ADPDF ADXAS ADZCM ADZMN ADZOD AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFFNX AFGKR AFKRA AFKVX AFPWT AFZJQ AHMBA AI. AIACR AIJEM AIURR AIWBW AJBDE AJWEG ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BROTX BRXPI CAG CCPQU COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DRFUL DRMAN DRSTM DUUFO EBS EJD EMOBN ESX EX3 F00 F01 F04 F21 F5P FEDTE FUBAC FYUFA G-S GODZA H.X HF~ HMCUK HVGLF HZ~ IHE KBYEO L7B LATKE LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M44 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM MY~ N04 N05 NF~ O66 OK1 OVD OVEED P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N QB0 R.K RIWAO RJQFR ROL RPM RX1 SAMSI SUPJJ TDBHL TEORI TFW UKHRP V9Y VH1 W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WVDHM WXSBR X7M YFH ZGI ZXP ZZTAW ~IA ~WT AAFWJ AAMMB AAYXX AEFGJ AFPKN AGQPQ AGXDD AIDQK AIDYY AIQQE AQTUD CITATION GROUPED_DOAJ O8X PHGZM WIN CGR CUY CVF ECM EIF NPM K9. 7X8 |
| ID | FETCH-LOGICAL-c4596-655ab9f7114ed1f39faf66c9957af6bdad9b1ace48cf6f73e5d8bef9045d7e3b3 |
| IEDL.DBID | WIN |
| ISICitedReferencesCount | 73 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000465133700012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0001-6349 1600-0412 |
| IngestDate | Sat Sep 27 17:00:05 EDT 2025 Sat Nov 29 14:43:29 EST 2025 Wed Feb 19 02:31:46 EST 2025 Tue Nov 18 21:28:54 EST 2025 Sat Nov 29 06:00:22 EST 2025 Wed Jan 22 17:04:00 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Keywords | cancer fertility preservation ovarian tissue cryopreservation children gonadotoxic treatment |
| Language | English |
| License | 2019 Nordic Federation of Societies of Obstetrics and Gynecology. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4596-655ab9f7114ed1f39faf66c9957af6bdad9b1ace48cf6f73e5d8bef9045d7e3b3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-8043-7506 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/aogs.13616 |
| PMID | 30919447 |
| PQID | 2211290005 |
| PQPubID | 1136361 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_2199191263 proquest_journals_2211290005 pubmed_primary_30919447 crossref_primary_10_1111_aogs_13616 crossref_citationtrail_10_1111_aogs_13616 wiley_primary_10_1111_aogs_13616_AOGS13616 |
| PublicationCentury | 2000 |
| PublicationDate | May 2019 |
| PublicationDateYYYYMMDD | 2019-05-01 |
| PublicationDate_xml | – month: 05 year: 2019 text: May 2019 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Reykjavik |
| PublicationTitle | Acta obstetricia et gynecologica Scandinavica |
| PublicationTitleAlternate | Acta Obstet Gynecol Scand |
| PublicationYear | 2019 |
| Publisher | John Wiley & Sons, Inc |
| Publisher_xml | – name: John Wiley & Sons, Inc |
| References | 2002; 17 2012; 2012 2009; 53 2013; 49 2009; 92 2017; 32 2015; 30 2013; 30 2003; 79 1997; 19 2018; 70 2014; 15 2016; 31 2019 1999; 86 2001; 16 2007; 42 2012; 379 2017; 377 1996; 87 2010; 6 2018; 14 2007; 49 e_1_2_9_11_1 e_1_2_9_10_1 e_1_2_9_13_1 e_1_2_9_12_1 Sanders JE (e_1_2_9_22_1) 1996; 87 Jensen AK (e_1_2_9_6_1) 2017; 32 Matthews SJ (e_1_2_9_27_1) 2018; 70 e_1_2_9_15_1 Bernaudin F (e_1_2_9_21_1) 1997; 19 e_1_2_9_14_1 e_1_2_9_17_1 e_1_2_9_16_1 e_1_2_9_19_1 e_1_2_9_18_1 e_1_2_9_20_1 e_1_2_9_24_1 e_1_2_9_23_1 e_1_2_9_8_1 e_1_2_9_7_1 e_1_2_9_5_1 e_1_2_9_4_1 e_1_2_9_3_1 e_1_2_9_2_1 e_1_2_9_9_1 e_1_2_9_26_1 e_1_2_9_25_1 |
| References_xml | – year: 2019 article-title: A prospective study of women and girls undergoing fertility preservation due to oncologic and non‐oncologic indications in Sweden – Trends in patients' choices and benefit of the chosen methods after long‐term follow up publication-title: Acta Obstet Gynecol Scand – volume: 30 start-page: 3 year: 2013 end-page: 9 article-title: Evaluation of ovarian and testicular tissue cryopreservation in children undergoing gonadotoxic therapies publication-title: J Assist Reprod Genet – volume: 31 start-page: 750 year: 2016 end-page: 762 article-title: Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy publication-title: Hum Reprod – volume: 86 start-page: 697 year: 1999 end-page: 709 article-title: Having children after cancer. A pilot survey of survivors' attitudes and experiences publication-title: Cancer – volume: 49 start-page: 911 year: 2013 end-page: 914 article-title: Case report: stimulation of puberty in a girl with chemo‐ and radiation therapy induced ovarian failure by transplantation of small part of her frozen/thawed ovarian tissue publication-title: Eur J Cancer – volume: 6 start-page: 617 year: 2010 end-page: 630 article-title: Fertility preservation in girls during childhood: is it feasible, efficient and safe and to whom should it be proposed? publication-title: Hum Reprod Update – volume: 49 start-page: 74 year: 2007 end-page: 78 article-title: Feasibility of ovarian tissue cryopreservation for prepubertal females with cancer publication-title: Pediatr Blood Cancer – volume: 70 start-page: 432 year: 2018 end-page: 435 article-title: Successful pregnancy in a woman previously suffering from β‐thalassemia following transplantation of ovarian tissue cryopreserved before puberty publication-title: Min Ginecol – volume: 42 start-page: 862 year: 2007 end-page: 864 article-title: Laparoscopic ovarian tissue preservation in young patients at risk for ovarian failure as a result of chemotherapy/irradiation for primary malignancy publication-title: J Pediatr Surg – volume: 379 start-page: 588 year: 2012 article-title: Induction of puberty by autograft of cryopreserved ovarian tissue publication-title: Lancet – volume: 92 start-page: 458 year: 2009 end-page: 463 article-title: At what age can human oocytes be obtained? publication-title: Fertil Steril – volume: 30 start-page: 2107 year: 2015 end-page: 2109 article-title: Live birth after autograft of ovarian tissue cryopreserved during childhood publication-title: Hum Reprod – volume: 14 start-page: 363 year: 2018 end-page: 378 article-title: Ovarian tissue cryopreservation in young females through the Oncofertility Consortium's National Physicians Cooperative publication-title: Future Oncol – volume: 2012 start-page: 910698 year: 2012 article-title: Cryopreservation of ovarian tissue in pediatric patients publication-title: Obstet Gynecol Int – volume: 87 start-page: 3045 year: 1996 end-page: 3052 article-title: Pregnancies following high‐dose cyclophosphamide with or without high‐dose busulfan or total body irradiation and bone marrow transplantation publication-title: Blood – volume: 53 start-page: 267 year: 2009 end-page: 273 article-title: Fertility preservation medicine: a new field in the care of young cancer survivors publication-title: Pediatr Blood Cancer – volume: 2012 start-page: 139193 year: 2012 article-title: Fertility preservation in girls publication-title: Obstet Gynecol Int – volume: 79 start-page: 1237 year: 2003 end-page: 1239 article-title: Oocyte collection during cryopreservation of the ovarian cortex publication-title: Fertil Steril – volume: 32 start-page: 154 year: 2017 end-page: 164 article-title: Cryopreservation of ovarian tissue for fertility preservation in a large cohort of young girls: focus on pubertal development publication-title: Hum Reprod – volume: 377 start-page: 1657 year: 2017 end-page: 1665 article-title: Fertility preservation in women publication-title: N Engl J Med – volume: 19 start-page: 112 year: 1997 article-title: Report of the French experience concerning 26 children transplanted for severe sickle cell disease publication-title: Bone Marrow Transplant – volume: 17 start-page: 1447 year: 2002 end-page: 1452 article-title: Human ovarian tissue cryopreservation: indications and feasibility publication-title: Hum Reprod – volume: 16 start-page: 411 year: 2001 end-page: 416 article-title: Human oocyte cryopreservation: new perspective regarding oocyte survival publication-title: Hum Reprod – volume: 15 start-page: 1129 year: 2014 end-page: 1136 article-title: Fertility preservation for girls and young women with cancer: population‐based validation of criteria for ovarian tissue cryopreservation publication-title: Lancet Oncol – volume: 32 start-page: 1046 year: 2017 end-page: 1054 article-title: Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases publication-title: Hum Reprod – volume: 32 start-page: 154 year: 2017 ident: e_1_2_9_6_1 article-title: Cryopreservation of ovarian tissue for fertility preservation in a large cohort of young girls: focus on pubertal development publication-title: Hum Reprod – ident: e_1_2_9_13_1 doi: 10.1155/2012/139193 – ident: e_1_2_9_16_1 doi: 10.2217/fon-2017-0410 – ident: e_1_2_9_10_1 doi: 10.1002/pbc.22003 – ident: e_1_2_9_15_1 doi: 10.1002/pbc.21027 – volume: 70 start-page: 432 year: 2018 ident: e_1_2_9_27_1 article-title: Successful pregnancy in a woman previously suffering from β‐thalassemia following transplantation of ovarian tissue cryopreserved before puberty publication-title: Min Ginecol – ident: e_1_2_9_9_1 doi: 10.1093/humupd/dmq010 – ident: e_1_2_9_20_1 doi: 10.1016/S0140-6736(11)61781-9 – volume: 87 start-page: 3045 year: 1996 ident: e_1_2_9_22_1 article-title: Pregnancies following high‐dose cyclophosphamide with or without high‐dose busulfan or total body irradiation and bone marrow transplantation publication-title: Blood doi: 10.1182/blood.V87.7.3045.bloodjournal8773045 – ident: e_1_2_9_8_1 doi: 10.1016/j.fertnstert.2008.07.013 – ident: e_1_2_9_26_1 doi: 10.1093/humrep/dev128 – ident: e_1_2_9_12_1 doi: 10.1093/humrep/dew007 – ident: e_1_2_9_2_1 – ident: e_1_2_9_25_1 doi: 10.1016/j.ejca.2012.09.028 – ident: e_1_2_9_17_1 doi: 10.1111/aogs.13559 – ident: e_1_2_9_24_1 doi: 10.1056/NEJMra1614676 – ident: e_1_2_9_4_1 doi: 10.1093/humrep/17.6.1447 – ident: e_1_2_9_14_1 doi: 10.1155/2012/910698 – ident: e_1_2_9_18_1 doi: 10.1016/S0015-0282(02)04963-4 – ident: e_1_2_9_7_1 doi: 10.1016/j.jpedsurg.2006.12.041 – volume: 19 start-page: 112 year: 1997 ident: e_1_2_9_21_1 article-title: Report of the French experience concerning 26 children transplanted for severe sickle cell disease publication-title: Bone Marrow Transplant – ident: e_1_2_9_19_1 doi: 10.1093/humrep/16.3.411 – ident: e_1_2_9_5_1 doi: 10.1016/S1470-2045(14)70334-1 – ident: e_1_2_9_3_1 doi: 10.1002/(SICI)1097-0142(19990815)86:4<697::AID-CNCR20>3.0.CO;2-J – ident: e_1_2_9_11_1 doi: 10.1007/s10815-012-9909-5 – ident: e_1_2_9_23_1 doi: 10.1093/humrep/dex040 |
| SSID | ssj0012748 |
| Score | 2.5035377 |
| Snippet | Introduction
The preservation of fertility is an integral part of care of children requiring gonadotoxic treatments for cancer or non‐malignant diseases. In... The preservation of fertility is an integral part of care of children requiring gonadotoxic treatments for cancer or non-malignant diseases. In France, the... IntroductionThe preservation of fertility is an integral part of care of children requiring gonadotoxic treatments for cancer or non‐malignant diseases. In... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 630 |
| SubjectTerms | Adolescent Antineoplastic Agents - therapeutic use Antineoplastic Agents - toxicity cancer Child Child, Preschool children Cryopreservation Cryopreservation - methods Cryopreservation - statistics & numerical data Female Fertility fertility preservation Fertility Preservation - methods Fertility Preservation - statistics & numerical data France - epidemiology Girls gonadotoxic treatment Humans Infant Neoplasms - epidemiology Neoplasms - therapy Neuroblastoma Oocyte Retrieval Outcome and Process Assessment, Health Care ovarian tissue cryopreservation Ovary Procedures and Techniques Utilization - statistics & numerical data Reproductive technologies Retrospective Studies Teenagers Womens health |
| Title | Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Faogs.13616 https://www.ncbi.nlm.nih.gov/pubmed/30919447 https://www.proquest.com/docview/2211290005 https://www.proquest.com/docview/2199191263 |
| Volume | 98 |
| WOSCitedRecordID | wos000465133700012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAWR databaseName: Taylor & Francis Journals Complete customDbUrl: eissn: 1600-0412 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0012748 issn: 0001-6349 databaseCode: TFW dateStart: 19220101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis – providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 1600-0412 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0012748 issn: 0001-6349 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1600-0412 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0012748 issn: 0001-6349 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1baxQxFA61ivji_bJalyP6ojCls8lMJuBLaV0VdCva4r4NuS4Ly0yZ2a3uv-lfqb_Mk8zFLoogPk1gEhIm50u-k5z5DiEvaGyNlYmNcDuiEVPSRUIxHSnDjc605qlkIdkEn0yy6VR82iKvu39hGn2I_sDNIyOs1x7gUtWXQC7LWe2DtGKvtx2zgMqv7yf9FQK6W80yjP5ySplotUl9GM-vppu70W8Uc5Oxhi1nfOv_Bnub3GypJuw3tnGHbNniLrn-sb1Mv0cujs7QUZYFLMPHB12tQ0qU7pgWkM-C83HXnqrDxqt5ASzOYDavFjXIwsAlZShYncKyhDj5cb5GHNVQOsBVC5zEfmfgBZIXa5ihC4Aecfl9rqGPdt-F42_4WEPf0PZSzCCXIMEfbSxwrF5KtLpPTsZvjg_eRW1Gh0izRKRRmiRSCcfRCbMmdlQ46dJUC5FwLCgjjVCx1JZl2qWOU5uYTFknkHcabqmiD8h2URb2EYFMUWW9er0nTFSPlNlTe9ykNuNMKU0H5GU3s7lu5c591o1F3rk9fk7yMCcD8ryve9qIfPyx1k5nIHkL9DofjTxh9cx3QJ71rxGi_t5FFrZcYR0fXibiUYqDetgYVt8NRb4mGOMD8irYz1_6z_eP3n4Jpcf_UvkJuYEkTzRBmjtke1mt7FNyTZ-hcVVDcoVPsyG5evh5fPJhGBD0EyAoIo4 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3bjtMwELWgi4AX7pfCAoPgBaSgTe048eMKKIvodhF0pX2LfK0qVckqbRf6N_wKfBkzSRq2AiEhnmLJY9nSzNhn7MkZxp7z2DuvEx_hccQjYXSIlBE2Mi51NrM2lVrUxSbS8Tg7OVEf29wc-hem4YfoLtzIM-r9mhycLqTPebkupwvK0orlRbYj0I6SHtt582l4POqeETDkarZijJklF6rlJ6VUnl-jt0-k32DmNmqtj53h9f9c8A12rcWbsN8YyE12wRe32OXD9kX9Nvt-dIbRsi5gWWsAbLWu66Js7moBQS0ESr4mvA5bXbMCRJzBdFbNF6ALB-fooWB1CssS4uTHtzU60wLKALh1QdA47xSIJXm-hinGARgWl19nFrqU91cw-YKfNXQDfcfHDHoJGuh-Y45rJT7R6g47Hr6dvD6I2rIOkRWJkpFMEm1USDES8y4OXAUdpLRKJSk2jNNOmVhbLzIbZEi5T1xmfFAIPl3queF3Wa8oC3-fQWa48URhT6iJ24Fxe2YvddJnqTDG8j57sVFtblvOcyq9Mc83sQ_pJK910mfPOtnThunjj1K7GwvJW29f5IMBoVaCv332tOtGP6XHF134coUylGOm4oHERd1rLKubhiNoU0KkffayNqC_zJ_vH737XLce_IvwE3blYHI4ykfvxx8esquI-lSTtbnLestq5R-xS_YMDa163LrQT7zsJVI |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1taxQxEA7aSvGL7y-nVUf0i8JK95JNNh-L9VSs16It9NuS1-Pg2D3upXr_xr-iv8yZ3b21hyKInzaQCQnMTPJMMvsMY895GnwwWUjwOOKJsCYm2gqXWK-8y51T0oi62IQaDvOzM33c5ubQvzANP0R34UaeUe_X5OBh6uMFLzfVaE5ZWqm8zLZFpiX65fbBp8HpYfeMgCFXsxVjzCy50C0_KaXy_Bq9eSL9BjM3UWt97Ayu_-eCb7BrLd6E_cZAbrJLobzFdj62L-q32fejc4yWTQmLWgPgZqu6Lsr6rhYQ1EKk5GvC67DRNS5BpDmMxrPJHEzp4QI9FCynsKggzX58W6EzzaGKgFsXRIPzjoBYkicrGGEcgGFx9XXsoEt5fwUnX_Czgm5g6PiYwSzAAN1vTHCtxCc6u8NOB29OXr9L2rIOiSMtJTLLjNVRYSQWfBq5jiZK6bTOFDasN17b1LggchdlVDxkPrchagSfXgVu-V22VVZluM8gt9wGorAn1MRd3_o9u6e8DLkS1jreYy_Wqi1cy3lOpTcmxTr2IZ0UtU567FknO22YPv4otbu2kKL19nnR7xNqJfjbY0-7bvRTenwxZaiWKEM5ZjrtS1zUvcayumk4gjYthOqxl7UB_WX-Yv_o7ee69eBfhJ-wneODQXH4fvjhIbuKoE83SZu7bGsxW4ZH7Io7RzubPW496CcUcSTN |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ovarian+tissue+cryopreservation+for+fertility+preservation+in+418+girls+and+adolescents+up+to+15+years+of+age+facing+highly+gonadotoxic+treatment.+Twenty+years+of+experience+at+a+single+center&rft.jtitle=Acta+obstetricia+et+gynecologica+Scandinavica&rft.au=Poirot%2C+Catherine&rft.au=Brugieres%2C+Laurence&rft.au=Yakouben%2C+Karima&rft.au=Prades-Borio%2C+Marie&rft.date=2019-05-01&rft.issn=1600-0412&rft.eissn=1600-0412&rft.volume=98&rft.issue=5&rft.spage=630&rft_id=info:doi/10.1111%2Faogs.13616&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-6349&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-6349&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-6349&client=summon |